Highly Reversible Cycling of Zn-MnO Batteries Integrated with Acid-Treated Carbon Supportive Layer.

Small Methods

Next Generation Battery Research Center, Korea Electrotechnology Research Institute (KERI), 12, Jeongiui-gil, Seongsan-gu, Changwon-si, Gyeongsangnam-do, 51543, Republic of Korea.

Published: February 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Zn-MnO battery with mild-acid electrolytes has been considered as a promising alternative to Li-ion battery for safe and cost-effective energy storage systems (ESSs), and for full electrification. However, the governing mechanism of MnO electrochemistry has not been fully elucidated, hindering further advances in highly reversible MnO cathodes. Eventual Mn ion dissolution into the electrolyte adversely triggers the irreversible loss of Mn ions and the excessive precipitation of zinc hydroxyl sulfate (Zn SO (OH) ·xH O, ZHS), leading to irreversible capacity loss upon prolonged cycling. To overcome these drawbacks, a rationally renovated cell structure is proposed by integrating an acid-treated carbon supportive layer (aCSL) in the MnO cathode, which can play multifunctional roles rendering the additional reaction sites for the reversible formation/decomposition of ZHS and re-utilization of the dissolved Mn ions. Furthermore, the improved affinity of the aCSL toward the electrolyte is beneficial for increasing active surface area and facilitating charge transfer at the cathode side. Benefiting from these features, compared to the conventional cell configuration, the aCSL-integrated Zn-MnO cell exhibits superior cycling over 3000 cycles with negligible capacity decay (85.6% retention) at a current of 3 A g .

Download full-text PDF

Source
http://dx.doi.org/10.1002/smtd.202101060DOI Listing

Publication Analysis

Top Keywords

highly reversible
8
acid-treated carbon
8
carbon supportive
8
supportive layer
8
reversible cycling
4
cycling zn-mno
4
zn-mno batteries
4
batteries integrated
4
integrated acid-treated
4
layer zn-mno
4

Similar Publications

Carbonate esters as green alternatives in chromatographic separations.

Anal Chim Acta

November 2025

Department of chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, USA. Electronic address:

Background: Carbonate esters are polar aprotic solvents that can be used to replace polar solvents: methanol, acetonitrile, or even apolar solvents in the mobile phases for liquid chromatography. Dimethyl, diethyl, and propylene carbonates (DMC, DEC, and PC) are not fully soluble in water.

Results: Twelve volume phase diagrams of water, the three carbonates, and methanol, ethanol, propanol, and acetonitrile were determined.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) was a highly aggressive and metastatic subtype of breast cancer characterized by a poor prognosis and limited treatment options. Clarifying the underlying molecular mechanisms was of significant clinical importance. In this study, we We plotted Kaplan-Meier survival curves based on data from the Human Cancer Database and found that elevated CYPJ expression increased patient mortality risk and decreased survival rates.

View Article and Find Full Text PDF

Renal fibrosis is the common pathological outcome of chronic kidney disease (CKD) progressing into end-stage renal disease. The excessive proliferation of fibroblasts plays an important role in the CKD progression. Nutrients such as amino acids and their transportation are essential for cell proliferation.

View Article and Find Full Text PDF

Plastics are widely used materials composed of polymers and various additives to achieve specific properties. Their composition is often highly complex, particularly in post-consumer plastic waste. As mechanical recycling faces increasing limitations, chemistry-driven strategies are attracting growing interest to improve plastic recovery.

View Article and Find Full Text PDF

Introduction: Ischemic heart disease (IHD) constitutes the most prevalent form of cardiac disease in the general population. Although current therapeutic interventions have significantly improved both quality of life and survival rates, no available treatment can reverse the loss of cardiomyocytes resulting from ischemic injury. Existing therapies are limited to attenuating myocardial damage, reducing its extent, and mitigating its clinical consequences.

View Article and Find Full Text PDF